The ASRA releases its fifth iteration of evidence-based guidelines on regional anesthesia in patients on antithrombotic or ...

Although the benefits of thrombolytic therapy are well established in patients younger than age 75 years with acute ST-elevation myocardial infarction, the value of thrombolytic treatment in ...

Fibrinolytic therapy, also known as thrombolytic therapy, is used to lyse acute blood clots by activating plasminogen, resulting in the formation of plasmin, which cleaves the fibrin cross-links ...

LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...

Thrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonstrate improved clinical outcomes as compared to placebo, according to a ...

The American Stroke Association (ASA) announced the presentation of the DISTAL study, which is investigating whether endovascul ...

Chinese clinical scientist Wang Yongjun delivers a keynote speech at the 2025 International Stroke Conference (ISC) held in ...

A scientific statement regarding the management of patients with stroke in rural settings with lower resources has been published by the AHA.

In the acute setting, we agree with MacEwen that thrombolytic thrombolytic therapy in select cases of thrombosis and embolism should be endorsed until further evidence emerges. For longer term ...